Issue date: February 2011; Review date: December 2013.
"This guidance was developed using the single technology appraisal process."
Pazopanib for the first-line treatment of advanced renal cell carcinoma by National Institute for Health and Clinical Excellence. Published by National Institute for Health and Clinical Excellence in 2011. Publication and catalogue information, links to buy online and reader comments.